Leukaemia Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older.
- People who have been diagnosed with a myeloproliferative neoplasm (such as polycythemia vera, essential thrombocythemia, or low-risk primary myelofibrosis) or chronic myeloid leukemia, confirmed according to World Health Organization standards.
- People whose condition and treatment have been stable for at least 8 weeks before enrolling.
- People who are experiencing a meaningful level of fatigue, as measured by validated disease-specific questionnaires.
- People whose overall health condition is suitable for taking part in a supervised exercise program of at least moderate intensity.
- People who have no medical reasons preventing them from undergoing cardiopulmonary exercise testing (a test that measures how the heart and lungs respond to physical activity).
- People who have not taken part in any structured exercise or rehabilitation program in the 3 months before enrolling.
- People whose blood counts meet minimum safety levels (hemoglobin above 10 g/dL and platelets above 100,000 × 10⁹/L).
- People who are able to understand and follow the study procedures.
- People who have provided written consent to participate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with unstable heart or cardiovascular conditions, including uncontrolled heart failure, a recent heart attack or ischemia, significant irregular heart rhythms, or unexplained fainting episodes.
- People who have had a blood clot or serious bleeding episode within the 3 months before enrolling.
- People with an active acute or ongoing chronic infection.
- People with severe bone, joint, or neurological conditions that limit their ability to exercise or complete physical testing.
- People with serious systemic illnesses, such as advanced kidney or liver failure, an active second cancer, or an uncontrolled psychiatric condition.
- People whose overall clinical situation, in the treating doctor's judgment, could put their safety at risk or make it difficult to follow the study protocol.
- People who have been assessed by a rehabilitation specialist as needing a dedicated primary rehabilitation program.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carmen Fava, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Phone: 00390115082224
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility: Adherence to Exercise Program; Feasibility: Retention Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.